Protagenic Therapeutics (PTIX PINK) stock market data APIs
$0.9162
-0.18(-19.6%)
as of September 18, 2026
Try our APIs with
free plan!
Protagenic Therapeutics Financial Data Overview
Price chart is built with
Anychart
Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. The company was founded in 2004 and is based in New York, New York.
Prev. Close
0.9162
Open
0.7331
High
0.9181
Low
0.7328
52 wk Range
0.1282-4.55
Market Cap
1 655 K
Shares Outstanding
1 810 K
EPS
-0.5323
Beta
0.377
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Protagenic Therapeutics data using free add-ons & libraries
Get Protagenic Therapeutics Fundamental Data
Protagenic Therapeutics Fundamental data includes:
- Net Revenue:
- EBITDA: -4 211 627
- Earnings Per Share: -13
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-08-31
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Protagenic Therapeutics News
New
Protagenic Therapeutics Appoints Industry Veteran Bill Nichols Jr. as President to Accelerate Advancement of First-in-Class TCAP Pathway Therapy PT00114
NEW YORK, NY / ACCESS Newswire / April 23, 2026 / Protagenic Therapeutics, Inc. (OTCQB:PTIX), a clinical-stage biopharmaceutical company pioneering first-in-class neuropeptide therapies for stress-rel...
Protagenic Therapeutics receives Nasdaq non-compliance letter
Protagenic Therapeutics (PTIX [https://seekingalpha.com/symbol/PTIX]) has received a notification letter from Nasdaq indicating its non-compliance with the exchange’s listing rules, namely the minim...
Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice
NEW YORK, NY / ACCESS Newswire / November 27, 2025 / Protagenic Therapeutics, Inc. (Nasdaq:PTIX) (the "Company") today announced that it has received a notification letter from the Nasdaq Listing Qual...
Wondering what's happening in today's after-hours session?
After the closing bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session. [postmarket] AFTER HOURS GAINERS TICKER CHANGE ...
Get Protagenic Therapeutics fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
